Emphasis on Technology [Molecular Assay Technologies (PCR-Based Molecular Assays, Sequencing Based Molecular Assays), Non-Molecular Assay Technologies], Product & Service (Reagents & Consumables, Instruments, Software & Services); Transplant Type (Solid Organ Transplantation Stem Cell Transplantation, Soft Tissue Transplantation, Bone Marrow Transplantation); Application (Diagnostic, Research); End-User (Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories & Academic Institutes); and Region & Country.
Transplant diagnostics are tests used to determine whether the donor and receiver of an organ are compatible before or after transplant. The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing number of organ transplant, and technological advancements in the field of transplant diagnostics. In 2019, the rate of patients having transplanted organs in several nations around the world. During this year, France had a rate of roughly 87 organ transplant patients per million inhabitants. If blood and oxygen are flowing through the organs until the moment of recovery, organ donation can be done by both a deceased and a living donor. The increased rate of organ transplantation is due to the increase in diseases causing severe organ damages. This has been boosting the demand for diagnostic transplants.
Although there are more than 107,453 waiting for organ transplants, there has been a steady rise in the number of donor rates, followed by the deceased donor rate. For instance, as per Global Observatory on Donation and Transplantation (GODT), number of live kidney donors increased by 3.3%b whereas number of deceased donors increased by 8.1% from 2018 to 2019. This shows the improvement and demand for more diagnostics facilities across the healthcare sector related to transplant. The increase in number of organ donors is expected to be very lucrative for growth and dominance of transplant over the forecast period.
In the last decade, healthcare spending in those countries has remained about in line with total economic growth. Between 2010 and 2019, health spending in the OECD averaged around 8.7% of GDP every year. In the same time span, however, healthcare spending in the United States increased from 16.3 percent to 17.0 percent of GDP.
As per OECD data of 2019, the United States accounted for highest per capita GDP of 17% followed by Switzerland and Germany with GDP of 12.1% and 11.7%, respectively. The improvement in healthcare is expected to boost the market for Transplant Diagnostics Market
Organ transplant worldwide, 2019 (per million population)
Bio-Rad laboratories, Inc., Dorel Industries Inc., F. Hoffman-La Roche Ltd., QIAGEN N.V., Thermo Fisher Scientific Inc., bioMérieux S.A., Immucor, Inc., llumina, Inc., Luminex Corporation, Becton, Dickinson and Company, are some of the prominent players operating in the global Transplant Diagnostics market. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.
Insights Presented in the Report
“Amongst Technology, Molecular Assay Technologies segment holds the major share”
Based on technology, the market is fragmented into molecular assay technologies, and non-molecular assay technologies. Further, the molecular technologies studied into PCR-based molecular assays, sequencing based molecular assays. The molecular assay technologies segment dominated the market with a share of XX% in 2020 and is expected to maintain its dominance during the forecast period owing to the increasing public-private financing for target research efforts and the expanding burden of infectious illnesses.
“Amongst Product & Service, Instruments is anticipated to grow at the highest CAGR during the analyzed period”
Further based on product & service, the market is fragmented into reagents & consumables, instruments, software & services. In 2020, instruments accounted for a maximum market revenue share of XX% and is expected to remain dominant during the analyzed period owing to the increasing healthcare expenditures.
Amongst Transplant Type, Solid Organ Transplantation segment holds the major share”
Based on the transplant type, the market is fragmented into solid organ transplantation stem cell transplantation, soft tissue transplantation, and bone marrow transplantation. The solid organ transplantation centers dominated the market in 2020 with revenue of USD XX billion and is anticipated to maintain its dominance during the analyzed period. Furthermore, the segment is also expected to grow at the highest CAGR during the period.
Amongst Application, Diagnostic Application segment holds the major share”
Based on the application, the market is fragmented into diagnostic applications and research applications. The diagnostic applications centers dominated the market in 2020 with revenue of USD XX billion and is anticipated to maintain its dominance during the analyzed period on account of its varied applications in patient profiling and increasing clinical evidence of its efficacy.
Amongst End-User, Independent Reference Laboratories segment holds the major share”
Based on the end-user type, the market is fragmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. The independent reference laboratories dominated the market in 2020 with revenue of USD XX billion and is anticipated to maintain its dominance during the analyzed period owing to the growing number of research & development activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories.
“North America signifies one of the largest markets of Transplant Diagnostics Market”
For a better understanding of the market dynamics of the Transplant Diagnostics market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX billion in 2020 owing to factors such as highly developed healthcare infrastructure and the availability of skilled professionals. Moreover, the high adoption of personalized medicines, stem cell therapies, and soft tissue transplants are augmenting the regional market growth. Although there are 107,453 of individuals are in the waiting list waiting list in USA but at the same time the number of donors are also increasing at a good pace.
Reasons to buy this report:
Customization Options:
The Transplant Diagnostics Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Top Start-ups Under Transplant Diagnostics Industry
6. Covid-19 Impact
7. Global Transplant Diagnostics Market Revenue
8. Market Insights By Technology
9. Market Insights By Product & Services
10. Market Insights By Transplant Type
11. Market Insights By Application
12. Market Insights By End-user
13. Market Insights By Region
14. Baby Monitor Market Dynamics
15. Legal & Regulatory Framework
16. Demand And Supply Side Analysis
17. Value Chain Analysis
18. Transplant Diagnostics Market Opportunities
19. Transplant Diagnostics Market Trends & Insights
20. Competitive Scenario
21. Company Profiled
22. Disclaimer
Analyzing the historical market, estimation of the current market, and forecasting the future market of the Global Transplant Diagnostics Market were the three major steps undertaken to create and analyze the adoption of organ and tissue transplants for the different diseases across major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the Transplant Diagnostics sector. Post assumption and validation of market numbers through primary interviews, we employed a top-down/Bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detailed secondary study was conducted to obtain the historical market size of the Transplant Diagnostics through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Transplant Diagnostics market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments for major regions. Major segments included in the report are therapy, application, and end-user. Further country-level analyses were conducted to evaluate the overall adoption of Transplant Diagnostics in every region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of Transplant Diagnostics. Further, we conducted factor analysis using dependent and independent variables such as increasing chronic disease, growing geriatric population. A thorough analysis was conducted for demand and supply-side scenario considering top partnerships, merger and acquisition, business expansion, and product launches in the Transplant Diagnostics industry across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Transplant Diagnostics market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e. top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the Transplant Diagnostics market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of technology, product & service, transplant type, application, and end-user of the Transplant Diagnostics market.
Main Objective of the Transplant Diagnostics Market Study
The current & future market trends of Transplant Diagnostics were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
